Resalis Therapeutics Revenue

Biotechnology Research • Turin, Piedmont, Italy • 11-20 Employees

Resalis Therapeutics revenue & valuation

Annual revenue	$1,500,000
Revenue per employee	$125,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,800,000
Total funding	$21,500,000

Key Contact at Resalis Therapeutics

Alessandro Toniolo

Chief Executive Officer E Amministratore Delegato

Company overview

Headquarters	Via Nizza, 52, Turin, Piedmont 10126, IT
Website	resalistherapeutics.com
NAICS	541714
Founded	2021
Employees	11-20
Socials

Resalis Therapeutics Email Formats

Resalis Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@resalistherapeutics.com), used 62.5% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@resalistherapeutics.com	62.5%
{first initial}.{last name}	j.doe@resalistherapeutics.com	37.5%

About Resalis Therapeutics

Resalis Therapeutics’ transformative metabolic disease approach targets a master regulator of key pathways underlying obesity and fatty liver disease. The company is applying its unique understanding of the non-coding RNA drug modality and lipid metabolism to develop its lead program, RES-010, into a safe and convenient treatment providing disease-modifying therapeutic impact including durable weight loss and reduction of hepatic steatosis. Building on robust preclinical evidence, Resalis will rapidly bring RES-010 into clinical trials for a range of metabolic disorders.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

Entry

C-Suite

Employees by Department

Resalis Therapeutics has 4 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Resalis Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-03-22	3	$10,600,000
2024-02-04	4	$10,900,000
2024-11-28	1	N/A
2024-11-28	19	N/A

Funding Insights

$21,500,000

Total funding amount

Number of funding rounds

Resalis Therapeutics Tech Stack

Discover the technologies and tools that power Resalis Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

Nginx

Reverse proxies

Aruba.it

Hosting

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

core-js

JavaScript libraries

RSS

Miscellaneous

MySQL

Databases

CookieYes

Cookie compliance

Priority Hints

Performance

Google Font API

Font scripts

Frequently asked questions

Resalis Therapeutics is located in Turin, Piedmont, IT.

Resalis Therapeutics generates an estimated annual revenue of $1,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Resalis Therapeutics has an estimated valuation of $4,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Resalis Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Resalis Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Resalis Therapeutics has raised a total of $21,500,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Resalis Therapeutics

Alessandro Toniolo

Chief Executive Officer E Amministratore Delegato

4.8

40,000 users